Abbreviated Name

Pancreatic Ref Set App: Honda (2014)

Lead Investigator

Honda, Kazufumi — National Cancer Center Research Institute

Coordinating Investigator

Feng, Ziding — Fred Hutchinson Cancer Center

Involved Investigators

• Feng, Ziding — Fred Hutchinson Cancer Center
• Honda, Kazufumi — National Cancer Center Research Institute

Abstact

See objectives

Aims

To improve the survival rate of pancreatic cancer, non-invasive diagnostic methods that detect the disease in its early stage must be developed.

Analytic Method

The National Cancer Institute (NCI) will send the pancreatic cancer reference serum samples to the National Cancer Center, and the National Cancer Center (NCC) will then blindly measure the levels of apoAII isoforms in the reference samples. NCC will return the data obtained from the reference set, and the NCI will subsequently calculate sensitivity, specificity, and the AUC. In addition, the NCI will evaluate the clinical utility for early detection of pancreatic cancer

Biomarkers

• ApoAII-ATQ/AT
• AT
• ATQ
• CA19-9

Data Collections

• No data available at this time for this protocol

Protocol ID

392

Field of Research

Proteomics

Collaborative Group

G.I. and Other Associated Cancers Research Group

Cancer Types

• Malignant neoplasm of pancreas

Phased Status

1